V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008623 | 190004707 | 1.82 | 115.5 | Curative (C) | 2017-04-14 | 2017-04-18 | null | 02 | N | RIBOCICLIB | 100687787 |
| 190008626 | 190004708 | 1.6 | 49 | Curative (C) | 2018-07-15 | 2018-07-20 | Cisplatin + Fluorouracil + RT 5day | null | null | CISPLATIN + GEMCITABINE | 100506170 |
| 190008638 | 190004709 | 1.68 | 87 | Adjuvant (A) | 2018-11-28 | 2018-11-29 | PEMBROLIZUMAB | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101067062 |
| 190008644 | 190004710 | 1.74 | 66.3 | Curative (C) | 2019-11-08 | 2019-11-08 | null | Y | N | PEMBROLIZUMAB | 101621193 |
| 190008646 | 190004711 | 1.98 | 20.3 | Curative (C) | 2021-12-06 | 2021-12-14 | PACLITAXEL | 02 | null | FLUOROURACIL + IRINOTECAN | 100578009 |
| 190008647 | 190004712 | 0 | 58.1 | null | 2018-09-21 | 2018-09-26 | null | 02 | N | STS NON-RHABDO EPSSG 2005 IE | 100996805 |
| 190008653 | 190004713 | 1.56 | 59.8 | Palliative (P) | 2017-10-28 | 2018-04-05 | EW Rel rEECur Gemcitabine/Docetaxel + GCSF | 02 | N | CARBOPLATIN + THIOTEPA + TOPOTECAN | 101682415 |
| 190008654 | 190004714 | 1.63 | 97.6 | Curative (C) | 2016-04-10 | 2016-04-13 | Trial Unspecified | Y | N | PACLITAXEL | 101252692 |
| 190008664 | 190004715 | 1.86 | 82 | Curative (C) | 2016-04-29 | 2018-02-09 | Cisplatin + Radiotherapy | 02 | Y | DOCETAXEL + NINTEDANIB | 101867880 |
| 190008669 | 190004716 | 1.64 | null | Adjuvant (A) | null | 2021-08-17 | VAI (Ifos 3g/m2) | 02 | N | FLUOROURACIL + IRINOTECAN | 100338900 |
| 190008671 | 190004717 | 1.58 | 68.7 | Curative (C) | 2017-06-07 | 2017-06-11 | GEMCARBO | 02 | N | PACLITAXEL | 101855085 |
| 190008673 | 190004718 | 1.55 | 69 | Palliative (P) | 2021-03-02 | 2021-03-03 | OST Mifamurtide | 02 | N | FEC + DOCETAXEL | 100300037 |
| 190008677 | 190004719 | 1.52 | 73.7 | Curative (C) | 2019-09-02 | 2019-11-09 | Irinotecan + Modified De Gramont | N | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100630635 |
| 190008679 | 190004720 | 1.63 | 55 | null | 2018-02-01 | 2018-02-10 | EW EuroEwing 2012 Arm B VC | 02 | N | CEMIPLIMAB | 100721567 |
| 190008681 | 190004721 | null | 84.5 | Palliative (P) | 2019-12-22 | 2020-01-13 | OST Euramos 1 Closed Trial - M | 02 | N | CISPLATIN + RT | 100685833 |
| 190008687 | 190004722 | 0 | 35 | Palliative (P) | 2018-04-10 | 2018-04-15 | EW Rel rEECur Irinotecan/Temozolomide | 01 | N | CISPLATIN + CYTARABINE + ETOPOSIDE + RITUXIMAB | 101280432 |
| 190008693 | 190004723 | 1.68 | null | Palliative (P) | 2018-06-25 | 2018-07-22 | Carboplatin + Paclitaxel (weekly) | 02 | Y | CARBOPLATIN + PACLITAXEL | 100593995 |
| 190008697 | 190004724 | 1.71 | null | Curative (C) | 2018-05-24 | 2018-05-24 | Cisplatin | N | N | CISPLATIN | 101483685 |
| 190008704 | 190004725 | 1.58 | 54.3 | null | 2019-10-17 | 2019-10-23 | ECX | 02 | N | CISPLATIN + RT | 101445578 |
| 190008716 | 190004727 | 1.56 | 86 | Curative (C) | null | 2021-07-14 | Dox + HD Mtx (post PAM) | null | N | CISPLATIN + GEMCITABINE | 100394790 |
| 190008730 | 190004728 | 1.87 | 63.4 | Curative (C) | 2017-05-27 | 2017-11-15 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | N | CARBOPLATIN + GEMCITABINE | 101266420 |
| 190008734 | 190004729 | 1.81 | 25 | null | 2018-11-28 | 2019-03-09 | Cisplatin 100 + RT(H&N) 1 day | Y | N | CISPLATIN | 101136109 |
| 190008738 | 190004730 | 1.56 | 82.6 | Curative (C) | null | 2016-11-18 | EW EuroEwing 2012 Arm B VC | 02 | N | CARBOPLATIN + ETOPOSIDE | 101142328 |
| 190008746 | 190004731 | 1.38 | 55.4 | Neo-adjuvant (N) | 2020-01-30 | 2020-02-23 | Docetaxel 100mg/m2 (21 day) | 02 | N | CABAZITAXEL | 101063936 |
| 190008752 | 190004732 | 1.71 | 57 | null | 2020-03-05 | 2020-03-05 | Oxaliplatin + Modified de Gramont | 02 | N | OXALIPLATIN + MDG | 100001977 |
| 190008759 | 190004733 | 1.72 | 69.6 | Curative (C) | null | 2017-08-28 | Dox + HD Mtx (post PAM) | 02 | N | EC | 100237059 |
| 190008761 | 190004734 | 1.8 | 63 | null | 2020-12-24 | 2021-01-19 | CARBOPLATIN + GEMCITABINE | 02 | N | FLUOROURACIL + IRINOTECAN | 101780788 |
| 190008763 | 190004735 | 0 | 56.9 | Neo-adjuvant (N) | 2020-02-29 | 2020-03-14 | Paclitaxel 80mg/m2 day 1 8 15 | 01 | N | TRIAL UNSPECIFIED | 101179629 |
| 190008770 | 190004736 | 1.63 | 69 | Curative (C) | 2015-12-06 | 2018-08-30 | EW EuroEwing 2012 Arm B VDC | 02 | N | OCTREOTIDE | 100692820 |
| 190008772 | 190004737 | 1.66 | 57 | Palliative (P) | 2017-05-26 | 2017-05-28 | Cyclophosphamide + Vincristine | 01 | null | DOXORUBICIN + OLARATUMAB | 101132865 |
| 190008778 | 190004738 | 0 | 57 | Curative (C) | 2016-06-08 | 2016-06-09 | EW EuroEwing 2012 Arm B VDC/IE | 02 | N | CAPECITABINE + OXALIPLATIN | 100330975 |
| 190008779 | 190004739 | 1.81 | 74.7 | Adjuvant (A) | 2016-12-07 | 2017-05-27 | CARBOPLATIN + PACLITAXEL | N | N | CARBOPLATIN + PACLITAXEL | 100199904 |
| 190008781 | 190004740 | 0 | 12.8 | null | 2020-04-12 | 2020-04-23 | OST Euramos 1 Closed Trial - AP | 02 | N | CISPLATIN + GEMCITABINE | 100245881 |
| 190008784 | 190004741 | 1.63 | null | Neo-adjuvant (N) | 2018-03-31 | 2018-04-23 | Oxaliplatin + Modified de Gramont | 02 | N | CARBOPLATIN + ETOPOSIDE | 100997162 |
| 190008786 | 190004742 | 1.62 | 49 | Curative (C) | 2018-12-29 | 2018-12-29 | CISPLATIN + RT | 02 | N | CISPLATIN | 100012646 |
| 190008787 | 190004743 | 0 | 12.5 | null | null | 2017-03-20 | null | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101771553 |
| 190008789 | 190004744 | 1.78 | 66 | Palliative (P) | 2016-04-20 | 2016-04-24 | STS Non-Rhabdo EpSSG 2005 Vinorelbine | 02 | N | CARBOPLATIN + THIOTEPA + TOPOTECAN | 101074975 |
| 190008797 | 190004745 | 1.9 | 93.5 | Curative (C) | 2018-10-26 | 2018-12-06 | EW EuroEwing 2012 Arm A VAI | 02 | null | AVELUMAB | 100159544 |
| 190008798 | 190004746 | 1.58 | 61.5 | Curative (C) | 2015-10-23 | 2015-11-07 | Etoposide + Ifosfamide (5 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101760477 |
| 190008800 | 190004747 | 1.88 | 77 | Palliative (P) | 2017-04-22 | 2017-05-07 | GEMCITABINE | 02 | Y | CARBOPLATIN + FLUOROURACIL | 101646189 |
| 190008801 | 190004748 | 0 | 0 | Adjuvant (A) | 2016-07-24 | 2016-07-24 | Irinotecan + Modified De Gramont | 02 | N | TOPOTECAN | 100464005 |
| 190008805 | 190004749 | 1.72 | 53.2 | null | null | 2018-07-25 | CARBOPLATIN + PACLITAXEL | Y | N | CARBOPLATIN + PACLITAXEL | 100930114 |
| 190008807 | 190004750 | 1.6 | 69.7 | Neo-adjuvant (N) | 2019-09-23 | 2019-09-23 | null | 99 | Y | STS NON-RHABDO EPSSG 2005 VDC/IE | 100749107 |
| 190008808 | 190004751 | 1.58 | 62.4 | null | 2018-09-19 | 2019-02-23 | GEMCARBO | null | null | OXALIPLATIN + MDG | 100506916 |
| 190008809 | 190004752 | 1.72 | 76.25 | Curative (C) | 2018-06-12 | 2018-06-20 | OST Mifamurtide | N | null | CISPLATIN + GEMCITABINE | 101114688 |
| 190008813 | 190004753 | null | 70.9 | null | null | 2018-04-21 | Capecitabine (14 days)+Carboplatin | null | null | CISPLATIN + RT | 101637746 |
| 190008816 | 190004754 | 1.5 | 62.6 | Palliative (P) | null | 2020-01-03 | Cisplatin | N | N | CISPLATIN | 101513382 |
| 190008817 | 190004755 | 1.59 | 61.5 | Curative (C) | 2019-03-07 | 2019-11-02 | EW Rel rEECur Irinotecan/Temozolomide | 01 | N | MELPHALAN | 101375934 |
| 190008819 | 190004756 | 0 | 18.8 | Curative (C) | 2018-12-15 | 2018-12-29 | Enzalutamide | 02 | N | CISPLATIN + LIPOSOMAL DOXORUBICIN | 100543326 |
| 190008821 | 190004757 | 1.7 | 48.4 | Curative (C) | 2017-10-10 | 2018-09-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100808096 |